Literature DB >> 11811931

Recent advances in understanding the mechanisms of TCDD immunotoxicity.

Nancy I Kerkvliet1.   

Abstract

TCDD is a highly immunosuppressive chemical that induces potent suppression of immune responses in laboratory animals. However, apart from the requisite role of the AhR and the identification of bone-marrow-derived cells as critical AhR-expressing targets, the specific cells and the underlying biochemical mechanisms by which TCDD disrupts immunological functions remain unclear. Recent data suggest that a new paradigm for the mechanism of immunotoxic action of TCDD may be more accurate, moving from one focused on the suppression of immune functions to one focused on the inappropriate activation of cells, leading to anergy or death, and the consequent premature termination of the immune response. Enhanced activation of B cells, DC and CD4+ T cells by TCDD has been described as well as the earlier disappearance of the latter two populations from peripheral lymphoid organs. Although much remains to be learned about how inappropriate cellular activation via the AhR induces immune suppression, deducing this mechanism of action and the signaling pathways involved, should lead to new insight into basic mechanisms of immune regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11811931     DOI: 10.1016/s1567-5769(01)00179-5

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  59 in total

1.  Consequences of AhR activation in steady-state dendritic cells.

Authors:  Tom Simones; David M Shepherd
Journal:  Toxicol Sci       Date:  2010-11-19       Impact factor: 4.849

2.  Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.

Authors:  Jinpeng Li; Ashwini S Phadnis-Moghe; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

3.  2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.

Authors:  Colin M North; Robert B Crawford; Haitian Lu; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2010-03-26       Impact factor: 4.849

4.  Targeted deletion of the aryl hydrocarbon receptor in dendritic cells prevents thymic atrophy in response to dioxin.

Authors:  Celine A Beamer; Joanna M Kreitinger; Shelby L Cole; David M Shepherd
Journal:  Arch Toxicol       Date:  2018-11-29       Impact factor: 5.153

5.  Statistically enhanced spectral counting approach to TCDD cardiac toxicity in the adult zebrafish heart.

Authors:  Jiang Zhang; Kevin A Lanham; Warren Heideman; Richard E Peterson; Lingjun Li
Journal:  J Proteome Res       Date:  2013-06-12       Impact factor: 4.466

Review 6.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

7.  The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice.

Authors:  Lewis Zhichang Shi; Nancy G Faith; Yumi Nakayama; Makulasiddappa Suresh; Howard Steinberg; Charles J Czuprynski
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

8.  Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.

Authors:  Iain A Murray; Jose L Morales; Colin A Flaveny; Brett C Dinatale; Chris Chiaro; Krishnegowda Gowdahalli; Shantu Amin; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

9.  Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.

Authors:  Rebecca A Henseler; Eric J Romer; Courtney E W Sulentic
Journal:  Toxicology       Date:  2009-03-31       Impact factor: 4.221

10.  Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.

Authors:  Qiang Zhang; Sudin Bhattacharya; Douglas E Kline; Robert B Crawford; Rory B Conolly; Russell S Thomas; Norbert E Kaminski; Melvin E Andersen
Journal:  BMC Syst Biol       Date:  2010-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.